Navigation Links
China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
Date:2/20/2008

NEW YORK, Feb. 20 /Xinhua-PRNewswire-FirstCall/ -- China Dongsheng International, Inc. (OTC Bulletin Board: CDSG), a leading developer and manufacturer of nutritional supplements and personal care products provider in China, today announced the Company's financial results for the fiscal year 2008 second quarter ended December 31, 2007.

-- Company's strategic plan realizes initial results of manufacturing its

own branded products in-house.

-- Second quarter gross profit increases 39% to $8.51 Million

-- Gross margin improves to 85% from 58% versus prior comparable period

-- Net income increases 12% to $4.33 Million quarter over quarter as the

net margin improves to 43.2% from 36.8%.

"We continue to execute our strategic plan to vertically integrate operations and focus on our own branded products. We are pleased to be able to increase our net earnings during this transition period while dramatically improving our gross margins," said Mr. Aidong Yu, Chairman of China Dongsheng International, Inc. "Moreover, we expect to see continued significant growth in profits from our branded products in the coming quarters as we continue to roll-out new production lines at our manufacturing facilities. With our extensive distribution, strong demand for our branded products, expanded R&D team, and our GMP certified manufacturing facilities, the Company is becoming increasingly well positioned to capitalize on the growth of the healthcare market in China"

Second Quarter Fiscal Year 2008 Results

Net sales for the fiscal year second quarter ended December 31, 2007 totalled $10.01 million and were relatively unchanged compared to the total of $10.49 million in the same period in 2006. This largely reflects our focus on our higher margin branded products manufactured in-house and discontinuing the distribution of certain lower margin products from third parties.

We sold 676,462 units of our Chitosan bas
'/>"/>

SOURCE China Dongsheng International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
2. China Holdings Announces Starwood Research Institute Initiates Research Coverage
3. China Display Technologies, Inc. to Present at Roth Conference
4. Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
5. Wall Street Reporter Spotlights China Holdings Inc. and Asias Hunger for Alternative Energy
6. Chinas Environment, Health Examined in New Wilson Center Report
7. Red Cross Partners with YeePay on China Snow Disaster Relief
8. China Sky One Medical Raises $25 Million in Private Placement
9. DuPont Opens Fluoropolymer Production Plant in China
10. China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
11. China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... According to a new market research report ... (processor, GPU, DSP, connectivity), Technology Node (45nm-5nm), Application ... Forecast and Analysis to 2014-2020", published by MarketsandMarkets, ... is expected to reach $61.70 Billion by 2020, ... to 2020. , Browse 71 market data Tables ...
(Date:7/13/2014)... 13, 2014 A Massachusetts couple who ... cancer risks associated with power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) ... to federal regulators, as they presented poignant testimony on ... Drug Administration (FDA) advisory panel meeting convened to address ... the Rochester Democrat and Chronicle, Dr. Hooman Noorchashm and ...
(Date:7/13/2014)... 2014 The Pearland, Texas location of The ... from four months to 12 years of age that offers ... birthday parties and Summer Camps, is now under new ownership. ... Pearland after spending over six years at The Little ... Director. , Berry has over ten years of experience ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 The federal ... ) filed against Johnson & Johnson’s Ethicon, ... trial, which is expected to get underway next month. ... the U.S. District Court, Southern District of West Virginia ... held on August 7, 2014 at 3:00 p.m. July ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Max ... Famer, Chris Mullin, will be the featured guest at ... 26th in Puerto Rico. Attendees will learn about ... participate in two exhibition basketball games and perform in ... supplier of health- and energy-boosting supplements , has ...
Breaking Medicine News(10 mins):Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4
... , , , ... http://www.avacor.com ) has acquired the assets ... name; Avacor,s FDA approved Physicians, Topical Formulation(R); the All-Natural Nutricap and ... Application) which allows the company to market and sell the FDA ...
... Going out like a brilliant flame is one way ... a form of programmed suicide called apoptosis, a desired effect ... could more quickly pick the most effective treatment. Now scientists ... way to do just that, by lighting up cells as ...
... A new study by researchers from the Automotive Safety Program ... Medicine published online July 13, 2009 in the journal ... health care needs are doing a good job with the ... help in using it correctly. The study, one of ...
... to aid in understanding childhood brain development and healthy ... Deficit Hyperactivity Disorder and detecting the early onset of ... million in recent funding from the Canadian Institutes of ... makes us human is the ability to control our ...
... , , WASHINGTON, July 13 ... creation of a National Diabetes Coordinator to develop and implement a nationwide ... , , A study commissioned by NCDP ... The coordinator would be responsible for establishing priorities in the fight ...
... , , , WASHINGTON, ... in Congress, the Institute for America,s Future today released the names ... All the experts favor a public health insurance option to compete with ... to the health care debate. , , ...
Cached Medicine News:Health News:Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group. 2Health News:Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows 2Health News:Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows 3Health News: Making the difficult task of transporting a child with special needs safer 2Health News:Queen's University study aims at early diagnosis for ADHD and Parkinson's disease 2Health News:Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment 2Health News:Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment 3Health News:Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment 4Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 2Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 3Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 4Health News:Prominent Health Experts Who Support Public Insurance Option Available for Interview 5
(Date:7/11/2014)... /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a new ... in portable vaporizers, which contains CBD, or cannabodiol. ... cannabidiol offers consumers a THC-free product made for ... technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... compounds which are currently known, two of which ...
(Date:7/11/2014)... July 11, 2014 The consumer marketing ... across industry sectors to better identify winning tools ... to engage with and understand consumers, as new ... make critical purchasing decisions. According ... LLC, one area where organizations can observe a ...
(Date:7/11/2014)... 11, 2014 Research and Markets ... Chinese Medical X-ray Film Industry Report 2014" report ... Global And Chinese Medical X-Ray Film ... on the current state of the Global medical X-ray ... The report provides a basic overview of the ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Technologies Transforming Consumer Marketing Research Playbook 2Global and Chinese Medical X-ray Film Industry Report 2014 2
... WELLESLEY, Mass., Oct. 26 Coley,Pharmaceutical Group, Inc. ... company,has received a $3.0 million milestone payment from ... III clinical trial in,non-small cell lung cancer (NSCLC) ... adjuvant. In June 2007, GSK announced the ...
... at AACR-NCI-EORTC ... Symposium, ... MTAX: CTIC) and Systems Medicine, LLC (SM), a,wholly-owned subsidiary of CTI, ... 19th annual AACR-NCI-EORTC Symposium. "These studies show potential progress toward ...
Cached Medicine Technology:Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 2Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 2Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 3Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 4Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development 5
Inquire...
Integrated closure system provides security you can feel as the plastic fasteners lock into place and is both easy to close, empty and clean....
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
Inquire...
Medicine Products: